User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

All Publications

Displaying 3 results.
    • Journal article
    Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
    Flaherty, Kevin R Wells, Athol U Cottin, Vincent Devaraj, Anand Walsh, Simon L F Inoue, Yoshikazu Richeldi, Luca Kolb, Martin Tetzlaff, Kay Stowasser, Susanne Coeck, Carl Clerisme-Beaty, Emmanuelle Rosenstock, Bernd Quaresma, Manuel Haeufel, Thomas Goeldner, Rainer-Georg Schlenker-Herceg, Rozsa Brown, Kevin K INBUILD Trial Investigators Dahlqvist, Caroline[UCL] (2019) The New England journal of medicine — Vol. 381, no. 18, p. 1718-1727 (2019)
    • Journal article
    Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study.
    Maher, Toby M Stowasser, Susanne Nishioka, Yasuhiko White, Eric S Cottin, Vincent Noth, Imre Selman, Moisés Rohr, Klaus B Michael, Andreas Ittrich, Carina Diefenbach, Claudia Jenkins, R Gisli INMARK trial investigators Dahlqvist, Caroline[UCL] (2019) The Lancet. Respiratory medicine — Vol. 7, no. 9, p. 771-779 (2019)
    • Journal article
    Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
    Distler, Oliver Highland, Kristin B Gahlemann, Martina Azuma, Arata Fischer, Aryeh Mayes, Maureen D Raghu, Ganesh Sauter, Wiebke Girard, Mannaig Alves, Margarida Clerisme-Beaty, Emmanuelle Stowasser, Susanne Tetzlaff, Kay Kuwana, Masataka Maher, Toby M SENSCIS Trial Investigators Houssiau, Frédéric[UCL] (2019) The New England journal of medicine — Vol. 380, no.26, p. 2518-2528 (2019)